Neal Walker, Director at Aldeyra Therapeutics, Inc. (ALDX), bought 6,250 shares at $8.00 ($50K) on 2014-05-07, disclosed to the SEC on 2014-05-08.
Open-market purchase of $50k ALDX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ACRS | SELL | 2023-01-04 | $960K | — | Filing → |
| ACRS | SELL | 2022-04-25 | $1.1M | — | Filing → |
| ACRS | SELL | 2022-03-14 | $1.8M | — | Filing → |